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Abstract
Background: The ability to specifically label proteins within living cells can provide information
about their dynamics and function. To study a membrane protein, we fused a multi-functional
reporter protein, HaloTag®, to the extracellular domain of a truncated integrin.
Results: Using the HaloTag technology, we could study the localization, trafficking and processing
of an integrin-HaloTag fusion, which we showed had cellular dynamics consistent with native
integrins. By labeling live cells with different fluorescent impermeable and permeable ligands, we
showed spatial separation of plasma membrane and internal pools of the integrin-HaloTag fusion,
and followed these protein pools over time to study bi-directional trafficking. In addition to
combining the HaloTag reporter protein with different fluorophores, we also employed an affinity
tag to achieve cell capture.
Conclusion: The HaloTag technology was used successfully to study expression, trafficking, spatial
separation and real-time translocation of an integrin-HaloTag fusion, thereby demonstrating that
this technology can be a powerful tool to investigate membrane protein biology in live cells.
Background
Membrane proteins are encoded by over 25% of all
sequenced open reading frames and constitute the major-
ity of known drug targets [1]. Therefore, tools providing a
greater understanding of membrane proteins may benefit
cell biology research and pharmacological development
[2-5]. The advance of methods for labeling proteins by
genetic fusion is expanding the understanding of protein
function in complex intracellular environments (see
recent reviews) [6-8]. Current reporter proteins such as
carrier proteins (i.e. peptidyl PCP or acyl ACP), tetra-
cysteine tags (i.e. Fluorescein and Resorufin Arsenical Hel-
ical binders), O6-alkylguanine-DNA alkyltransferase
(AGT), photoactivatable proteins and others (reviewed by
Chapman et al) allow more flexibility than originally
available with GFP [5,9-12]. However, visualization of
multiple pools of the same protein through space and
time can still be technically challenging and new options
could only benefit this expanding field.
The multifunctional HaloTag® technology complements
existing methods and provides new options to study spa-
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membrane protein. In addition, it can be used to study
protein topology and post-translational modification and
to capture cells. The HaloTag technology is based on the
formation of a covalent bond between the HaloTag
reporter protein and synthetic ligands [13]. The HaloTag
reporter protein is an engineered catalytically inactive
derivative of a bacterial hydrolase (Figure 1a). The syn-
thetic ligands contain two crucial components: 1) a com-
mon reactive linker that forms a covalent bond with the
HaloTag protein, and 2) a functional reporter such as a
fluorescent dye or an affinity handle such as biotin (Figure
1b). HaloTag ligands have the same chloroalkane reactive
linker, but differences in the functional reporter and dis-
tance of the reporter from the linker create an interchange-
able labeling technology. For instance, the HaloTag® TMR
ligand is a cell permeable red-emitting ligand, but unlike
some red fluorescent proteins like DsRed, it does not
require tetramerization (though directed evolution has
since created a monomeric red fluorescent protein)
[14,15]. The green-emitting HaloTag® Alexa Fluor® 488
and PEG-Biotin are cell impermeable ligands. The inter-
changeability of a broad range of ligands permits a variety
of functional studies of fusion proteins generated from a
single genetic construct (Figure 1c).
We used an integrin model to assess the applicability of
the HaloTag technology for observing the dynamics of
membrane protein processing and trafficking. Integrins
are membrane proteins that are central to cellular adhe-
sion and migration, thereby involving them in develop-
ment, inflammation, and disease [16-18]. Integrins are
heterodimers of α- and β-subunits, which typically have a
large extracellular domain, a single transmembrane seg-
ment and a short cytoplasmic tail [16]. Integrins have
been studied in living cells by fusing GFP to the intracel-
lular cytoplasmic tail or to the transmembrane domain
[19-21]. We fused the HaloTag reporter protein to the
extracellular domain of a truncated human β1 integrin
(β1Int-HaloTag, Figure 2a). By expressing the HaloTag
reporter protein on the cell surface, we were able to use the
multifunctional HaloTag technology to study a mem-
brane protein in living cells and to capture cells.
Results
The β1Int-HaloTag fusion protein was well tolerated by
multiple cell types, including mammalian cell lines and
human neural stem cells [22]. Immunocytochemistry
with β1 integrin and HaloTag antibodies showed that the
β1Int-HaloTag fusion protein was expressed at the cell
membrane in a similar pattern to endogenous β1 integrin
(Figure 2b). Fixed cells were non-permeabilized to show
that the HaloTag reporter protein was localized on the cell
surface.
To study membrane proteins in live cells with the HaloTag
technology, we developed a fluorescent ligand which
should not cross the cell membrane. To make this ligand
cell impermeable, we added a negatively charged dye to
the standard activated linker. To confirm that this novel
ligand, HaloTag® Alexa Fluor® 488 (HaloTag 488), was cell
impermeable, we labeled cells expressing HaloTag on the
surface or only inside. Live cell imaging showed that the
HaloTag 488 ligand specifically labeled the cell-surface
HaloTag protein in cells stably expressing β1Int-HaloTag,
but did not label the intracellular protein in cells stably
expressing HaloTag fused to a nuclear localization
sequence [23] (Figure 2c, d). This confirms that the novel
ligand is cell impermeable and that the surface HaloTag
protein fused to integrin can functionally bind ligands.
To reveal the β1Int-HaloTag protein topology and subcel-
lular distribution, we used HaloTag ligands with a modi-
fied fluorescence protease protection (FPP) assay [24].
The FPP assay, described by Lorenz (2006), determines
the topology and localization of proteins in living cells by
monitoring trypsin-induced destruction of GFP attached
to a protein of interest. We separately labeled surface and
internal protein pools of β1Int-HaloTag in live cells with
the cell impermeable fluorescent ligand, HaloTag 488,
followed by the cell permeable fluorescent ligand, Halo-
Tag TMR (Figure 3a). Spatial separation of protein pools
is depicted by a green rim around a red interior (Figure
3b). Trypsin exposure to live cells stripped the external
HaloTag 488 ligand over time, but preserved the internal
HaloTag TMR ligand (Figure 3a, b). This result shows that
the HaloTag protein fused to integrin was orientated on
the surface of the cell membrane, and that the multi-func-
tional HaloTag technology can be used to determine
topology of membrane proteins. In some instances, β1Int-
HaloTag labeled on the surface with the HaloTag 488 lig-
and was internalized before trypsin addition. Unlike the
surface exposed protein removed by trypsin, this recycled
protein showed fluorescence protease protection (Addi-
tional Figure 1).
To reveal the β1Int-HaloTag protein subcellular localiza-
tion, we combined the HaloTag technology and the per-
meabilization agent digitonin [24]. Cells were co-
transfected with β1Int-HaloTag and GFP, and then
labeled with the HaloTag TMR ligand (Figure 3c). Co-
expression of the proteins is shown by the yellow overlay
(Figure 3d). Digitonin treatment permeabilized the mem-
brane, which allowed freely floating GFP to diffuse out of
the cell over time while internally bound β1Int-HaloTag
was retained in the cell, presumably by cellular transport
and recycling machinery (Figure 3c, d). This result shows
that the HaloTag fusion did not affect normal processing
of a membrane bound protein, and that the HaloTag tech-Page 2 of 14
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Overview of HaloTag® TechnologyFigure 1
Overview of HaloTag® Technology. (a) Molecular model of the HaloTag protein. The HaloTag TMR ligand (fluorescent moiety 
in red, reactive linker in orange) is shown covalently bound to the aspartate nucleophile (blue). Replacement of catalytic base 
(His) with Phe renders the HaloTag protein inactive, leading to the formation of a stable covalent bond [13]. (b) Chemical 
structure of the HaloTag ligands showing the functional reporters and the reactive linker. HaloTag ligands have the same chlo-
roalkane reactive linker, but differ in the functional reporter and distance of the reporter from the linker. The HaloTag TMR 
ligand crosses the cell membrane, unlike the HaloTag PEG-Biotin and Alexa 488 Ligands. (c) The interchangeable HaloTag 
technology permits several cell-based applications, including live or fixed cell imaging and SDS-page analysis. Abbreviations: 
TMR, tetramethyl-rhodamine; His, histidine; Phe, phenylalanine.
BMC Cell Biology 2008, 9:17 http://www.biomedcentral.com/1471-2121/9/17nology can be used to distinguish free floating and mem-
brane bound proteins.
Membrane proteins, such as integrins, are typically traf-
ficked through secretory and endocytic pathways [25-27].
Permeabilization experiments showed β1Int-HaloTag was
retained in the cell, but to confirm that the β1Int-HaloTag
fusion protein was associated with intracellular transport
and recycling organelles, we combined fluorescent Halo-
Tag ligands to label live cells with fixed cell immunocyto-
chemistry. To assess protein delivery to the membrane,
live cells expressing β1Int-HaloTag were labeled with the
HaloTag TMR ligand, and then processed for immunocy-
tochemistry to visualize the endoplasmic reticulum (ER),
ER-intermediate golgi complex (ERIGC), or golgi (Figure
4a). To assess protein recycling from the membrane, live
cells expressing β1Int-HaloTag were labeled with the
HaloTag 488 ligand, and then processed for immunocyto-
chemistry to visualize the early and late endosomes (Fig-
ure 4b). Co-localization of the β1Int-HaloTag protein
with cellular transport machinery is shown by the yellow
overlay, and suggests that fusing HaloTag to the truncated
integrin does not alter normal protein flow through secre-
tory and endocytic pathways.
We used the HaloTag technology and immunocytochem-
istry to also show that the β1Int-HaloTag protein co-local-
ized with expected membrane proteins, such as cadherin
and transferrin receptors [20,28,29]. To assess protein co-
localization at the membrane, live cells expressing β1Int-
Targeting HaloTag protein to the cell surfaceFigure 2
Targeting HaloTag protein to the cell surface. (a) Human β1 integrin is depicted with a signal peptide (SP), extracellular domain 
(EC), transmembrane domain (TM) and cytoplasmic domain (CD) (left). In the β1Int-HaloTag construct, the HaloTag protein is 
displayed on the cell surface by fusion to the truncated (tr) extracellular domain of human β1 integrin (right). (b) Immunocyto-
chemistry, without permeabilization, using antibodies against integrin (green) and HaloTag (red) show that the β1Int-HaloTag 
fusion protein is being expressed in transfected HeLa Hcells, and the overlap of the two proteins (yellow) indicates β1Int-Halo-
Tag is expressed on the cell surface in a similar pattern to endogenous β1 integrin. (c) HEK293 cells stably expressing β1Int-
HaloTag labeled with the HaloTag 488 ligand show a green rim, confirming that HaloTag is on the surface and functional. (d) 
HEK293 cells stably expressing HaloTag-(NLS)3 labeled with the HaloTag 488 ligand do not show a green rim, confirming that 
the ligand is cell impermeable and does not label intracellular HaloTag protein. Cell images were generated on an Olympus 
FV500 confocal microscope using the appropriate filter.Page 4 of 14
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Revealing protein topology and subcellular localizationFigure 3
Revealing protein topology and subcellular localization. (a) Diagram of separately labeled surface and internal protein pools of 
β1Int-HaloTag, and trypsin exposure to strip the surface labeled pool. (b) Pre trypsin treatment, live HEK293 cells sequentially 
labeled with HaloTag 488 and TMR ligands show spatial separation of protein pools depicted by a green rim around a red inte-
rior. After trypsin, the external HaloTag 488 ligand is stripped over 50 and 450 seconds and the internal HaloTag TMR ligand is 
preserved. (c) Diagram of β1Int-HaloTag and GFP co-expression in TMR-labeled cells, and digitonin exposure to permeabilize 
membrane. (d) HeLa cells transfected with β1Int-HaloTag and GFP were labeled with HaloTag TMR ligand. Co-expression of 
the 2 proteins, shown by yellow overlay (arrow), is present pre digitonin treatment, but after digitonin most GFP diffuses out 
of the cells over 360, 440 and 590 seconds and β1Int-HaloTag remains inside (arrow). Cell images were generated on an Olym-
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then processed for immunocytochemistry (Figure 4b).
Co-localization of the β1Int-HaloTag protein with cad-
herin is shown by the yellow overlay, and suggests that
β1Int-HaloTag fusion not only traffics properly to the
membrane but also co-localizes with other expected
membrane proteins. To assesses protein co-internaliza-
tion from the membrane, live cells expressing β1Int-Halo-
Trafficking and internalization of membrane proteinsFigure 4
Trafficking and internalization of membrane proteins. (a) HeLa cells transiently expressing β1Int-HaloTag were labeled with 
the HaloTag TMR ligand, then fixed and processed for immunocytochemistry to visualize the endoplasmic reticulum (ER), ER-
golgi intermediate complex (ERGIC), or golgi followed by a green secondary antibody. (b) HeLa cells transiently expressing 
β1Int-HaloTag were labeled with the HaloTag 488 ligand, then fixed and processed for immunocytochemistry to visualize early 
endosomes (Rab4), late endosomes (Rab11) or cadherin followed by a red secondary antibody. (c) Hela cells transiently 
expressing β1Int-HaloTag were labeled with the HaloTag 488 ligand and an Alexa Fluor® 594 transferrin conjugate then fixed. 
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transferrin Alexa Fluor® 594 conjugate (Figure 4c). Co-
localization of the β1Int-HaloTag protein with the trans-
ferrin receptor is shown by the yellow overlay, and sug-
gests that the β1Int-HaloTag fusion not only internalizes
through the proper cellular machinery, but also co-inter-
nalizes with expected membrane proteins.
Mature integrins at the cell membrane are glycosylated,
and the internal pool is partially glycosylated as it traffics
through the secretory pathway [30]. To confirm that the
β1Int-HaloTag protein not only traffics normally through
the secretory pathway but also undergoes proper post-
translational modification, we used fluorescent HaloTag
ligands followed by SDS-PAGE analysis. Live cells express-
ing β1Int-HaloTag were sequentially labeled with Halo-
Tag 488 and TMR ligands to separately label surface and
internal proteins, respectively (Figure 1c). Lysate from
labeled cells showed two distinct protein pools on SDS-
PAGE in lane 2 (Figure 5a). This band pattern could be
because the higher molecular weight green surface pool of
β1Int-HaloTag is heavily glycosylated compared to the red
intracellular pool. To confirm whether the distinct protein
pools were due to differential protein glycosylation, we
glycanase treated cells lysates. Deglycosylation by either
O- or N-glycanase treatment caused a significant shift in
the green surface pool of β1Int-HaloTag (lane 3 and 4).
Conversely, O-glycanase treatment caused no visible shift
in the red internal pool of β1Int-HaloTag (lane 3), and N-
glycanase treatment caused only a minor shift (lane 4).
Glycanase treatment of the HaloTag reporter protein pro-
duced no band shift on SDS-PAGE (data not shown), sug-
gesting that the shift in β1Int-HaloTag is due to
glycosylation of the integrin protein. Our results show
that the surface pool of β1Int-HaloTag is glycosylated,
which is expected for integrins and suggests that fusing
HaloTag to a truncated integrin does not alter proper post-
translational glycosylation.
We also used the HaloTag technology to follow protein
modification over time. Cells expressing β1Int-HaloTag
were labeled sequentially with HaloTag 488 and TMR lig-
ands, and lysate was then collected immediately or up to
12 hours after labeling (Figure 5b). As expected, lysate
from cells labeled with the HaloTag TMR ligand alone
showed two protein pools (lane 1) and lysate from cells
labeled with the HaloTag 488 ligand alone showed only
the higher molecular weight protein pool (lane 2). Sub-
stantiating figure 5a, lysate from cells sequentially labeled
with both ligands showed separation of the two protein
pools at early time points (lanes 3–5). However, over time
the lower band for the red internal pool shifted up, pre-
sumably as this protein arrived at the membrane in a gly-
cosylated form (lanes 6–9) [31]. Additionally, the upper
band for the green surface pool disappeared, presumably
as this protein was endocytosed and degraded. The over-
laid SDS-PAGE shows that the HaloTag technology can be
used to track different protein pools and monitor post-
translational modifications over time.
Finally, we used the HaloTag technology and live cell
imaging to visualize spatial separation and real-time
translocation of β1Int-HaloTag. Cells expressing β1Int-
HaloTag were labeled sequentially with HaloTag 488 and
TMR ligands. Live cell imaging showed two distinct pro-
tein pools, with the surface protein labeled specifically
with the HaloTag 488 ligand and the intracellular protein
labeled with the HaloTag TMR ligand (Figure 5c). Re-
imaging 12 hours after labeling shows that the initial red
cytoplasmic pool has moved to the membrane and the
initial green surface pool has internalized (Figure 5d).
Timelapse imaging shows real-time translocation after
labeling, which begins with the green surface pool inter-
nalizing at 1 hour, continues with the red internal pool
trafficking to the surface, and ends with the red surface
pool internalizing (Additional Figure 2). The HaloTag
technology can show clear translocation of two separate
protein pools in live cells, and these results of β1Int-Halo-
Tag movement corroborate the immunocytochemistry
and SDS-PAGE results.
With the HaloTag technology, functional reporters such as
fluorescent ligands can be used to image live cells, and
affinity handles such as biotin can be used to capture cells
expressing HaloTag on the surface. We co-expressed
β1Int-HaloTag, or HaloTag as a control, with luciferase.
Live cells were labeled with HaloTag PEG-Biotin ligand
and then captured on streptavidin coated plates. Luci-
ferase assay results show the specific capture of β1Int-
HaloTag-expressing cells compared to HaloTag-expressing
control cells (Figure 6a). Specific capture of β1Int-Halo-
Tag-expressing cells was blocked when streptavidin coated
plates were pre-coated with HaloTag PEG-Biotin. In addi-
tion to the in vitro luciferase assay, live cell imaging con-
firms that β1Int-HaloTag-expressing cells can be
specifically captured using the HaloTag technology and
that captured cells survive. Live cells were labeled with
HaloTag PEG-Biotin ligand, captured on streptavidin
coated plates, and then replated for live cell imaging.
Labeling plated cells with the HaloTag TMR ligand shows
the survival of specifically captured β1Int-HaloTag-
expressing cells compared to control cells (Figure 6b).
Discussion
The ability to analyze proteins in their native environment
is critical to developing a detailed understanding of pro-
tein processing and trafficking. The study of protein traf-
ficking is particularly timely and valuable considering the
recently reported link between disrupted protein traffick-
ing and certain disease states [32,33]. The study of proteinPage 7 of 14
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recently reported by Lyly et al for palmitoyl protein
thioesterase I related to childhood encephalopathies [34].
We showed that the HaloTag technology can be used to
study the expression, topology, glyscosylation, distribu-
tion, and translocation of a vital cellular protein. This was
possible in multiple cell types, including mammalian cell
lines like CHO, HeLa, HEK293 and U2OS and also in
Spatial and temporal separation of proteins using HaloTag TechnologyFigure 5
Spatial and temporal separation of proteins using HaloTag Technology. (a) HEK293 cells stably expressing β1Int-HaloTag were 
sequentially labeled with the HaloTag 488 and TMR ligands and then rinsed and lysed. Lysate was non-glycanase treated (lane 
2), O-glycanase treated (lane 3) or N-glycanase treated (lane 4) and analyzed by SDS-PAGE with a ladder (lane 1). (b) HEK293 
cells stably expressing β1Int-HaloTag were labeled with the HaloTag TMR ligand alone (lane 1), the HaloTag 488 ligand alone 
(lane 2), or sequentially with the HaloTag 488 and TMR ligands (lanes 3–9). Cells were rinsed and lysed at 0 minutes (lanes 1–
3) or 0.5, 1, 2, 4, 8 and 12 hours (lanes 4–9) after labeling, and lysate was run on SDS-PAGE. (c) HeLa cells expressing β1Int-
HaloTag were sequentially labeled with the HaloTag 488 and HaloTag TMR ligands and imaged immediately after labeling to 
show spatially separated protein pools. (d) Cells were re-imaged 12 hours after labeling to show temporal translocation of 
both protein pools. Cell images were generated with Olympus FV500 confocal microscope in sequential mode using appropri-
ate filter sets.
1     2  3     4     5 6     7     8     9
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for antibodies is eliminated since the fixation-resistant
fluorescent HaloTag ligand directly detects the HaloTag
reporter protein fused to the protein of interest. Efficient
and flexible labeling of fusion proteins in live cells ena-
bles a fuller understanding of the protein's function.
By fusing the HaloTag gene to the extracelluar domain of
a truncated β1 integrin, we provided proof of concept that
the HaloTag reporter protein can be expressed on the cell
surface and can be used to study various aspects of mem-
brane protein biology. In addition to integrin, we have
successfully used the HaloTag technology to study the
biology of other membrane proteins, including glycosyl-
phosphatidylinositol (GPI) and the GABAA receptor (data
not shown). While we can not rule out subtle effects of the
HaloTag reporter protein on β1 integrin, we provide
strong evidence that integrin function was not affected.
Results showing that β1Int-HaloTag localized in a similar
pattern to endogenous integrin, trafficked and internal-
ized through expected intracellular machinery and fol-
lowed proper post-translational glycosylation suggest that
the integrin-HaloTag fusion protein maintained cellular
dynamics consistent with native integrins.
To specifically study surface-displayed HaloTag fused to
membrane proteins, we developed a novel HaloTag Alexa
488 ligand that we showed is cell impermeable and func-
tional. A previous report made an extracellular GFP-
integrin fusion and showed impressive focal adhesion
motility in live fibroblasts [21]. However, GFP was used
primarily as a fluorescent marker of the fusion protein
rather than the multifunctional HaloTag-integrin fusion
we used to spatially and temporally visualize integrin, to
determine integrin topology and post-translational modi-
fication and to capture live cells. In addition, GFP was
fused directly to the transmembrane domain with com-
plete removal of the extracellular domain. While we trun-
cated the integrin in our β1Int-HaloTag construct, we
intentionally retained portions of the extracellular and
cytoplasmic sequences and the specificity determining
loop (SDL) to ensure integrin traffics to the membrane
[35,36].
In addition to using the HaloTag technology to study
membrane protein biology, we have applied the HaloTag
technology to sort cells by fluorescent activated cell sort-
ing FACS [37]. We were able to successfully separate
β1IntHT2-expressing cells labeled with HaloTag TMR or
Alexa488 ligands from non-expressing cells (data not
shown). As an alternative method for cells sensitive to
FACS, the HaloTag technology can also be used to sort
cells by panning [38]. We showed that the technology can
be used to select cells by labeling surface-expressed Halo-
Tag with the PEG-Biotin ligand. Labeled cells can then be
captured on a streptavidin plate for in vitro assays or live
cell imaging.
Los and Wood (2006) previously described the HaloTag
technology simply for imaging intracellular proteins and
Cell capture using HaoTag TechnolgyFigure 6
Cell capture using HaoTag Technolgy. (a) HeLa cells co-expressing β1Int-HaloTag and luciferase were labeled with HaloTag 
PEG-Biotin. They show specific capture on SA plates compared to labeled cells co-expressing HaloTag and luciferase. Pre-coat-
ing plates with HaloTag PEG-Biotin blocks the specific capture. (b) HEK293 cells stably expressing β1Int-HaloTag (top panel) 
or wildtype HEK293 (bottom panel) were labeled with HaloTag PEG-Biotin. After capture and replate, cells were Tamra 
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on the cell surface and developing a fluorescent cell
impermeable ligand, we have greatly expanded this mul-
tifunctional technology to include visualizing different
pools of a membrane protein over space and time, assess-
ing post-translational modification, and capturing cells.
In addition, we combined the HaloTag technology with
FPP and digitonin permeabilization to study protein
topology and distribution.
The multifunctional HaloTag technology supports many
experimental procedures including immunocytochemis-
try, fixed and live cell imaging, SDS page, FPP and capture.
We successfully used this technology to determine protein
topology and subcellular localization, to capture and sort
cells, and to assess protein modification. In addition, we
used different colored cell impermeable and permeable
HaloTag ligands to show spatial separation of membrane
and internal protein pools, and real-time translocation of
these protein pools in live cells.
Conclusion
We have shown that the multifunctional HaloTag tech-
nology provides the ability to separate protein pools in
space and time, and could be a powerful tool to examine
the trafficking and cellular biology of membrane proteins
such as integrins or other proteins of interest.
Methods
HaloTag® protein and ligands
The HaloTag reporter protein is an engineered catalyti-
cally inactive derivative of a bacterial hydrolase [13].
Replacement of the catalytic base (His) with Phe renders
the HaloTag protein inactive by impairing its ability to
hydrolyze the ester intermediate, leading to the formation
of a stable covalent bond. The synthetic ligands contain
two crucial components: 1) a common reactive linker that
forms a covalent bond with the HaloTag® protein, and 2)
a functional reporter such as a fluorescent dye or an affin-
ity handle such as biotin. HaloTag® ligands have the same
chloroalkane reactive linker, but differ in the functional
reporter and distance of the reporter from the linker. The
HaloTag® TMR ligand crosses the cell membrane, unlike
the HaloTag® PEG-Biotin and HaloTag® Alexa Fluor® 488
Ligands.
HaloTag® ligand synthesis
The succinimidyl ester of Alexa Fluor® 488 carboxylic acid
was obtained from Invitrogen. Biotin-PEO4-propionate
succinimidyl ester was purchased from Biotium. All other
reagents and solvents for chemical syntheses were pur-
chased from Aldrich, Fisher, or VWR and were used with-
out further purification unless specified. Nuclear
Magnetic Resonance (NMR) was recorded on a Varian-
300. Mass data were obtained using a Fisions VG Platform
II spectrometer. UV-Vis absorption spectra were recorded
on Beckman DU 650 in 50 mM phosphate buffer (pH =
7.4). HPLC purification was accomplished using a Waters
Preparative HPLC with water and acetonitrile (ACN) as
mobile phase carriers applied to a Varian Microsorb 60-8
C18 column; 250 × 21.4 mm. Analytical HPLC was per-
formed on Agilent 1100 HPLC using a Synergi 4 µ Max-RP
80R, 250 × 4.6 mm C12 column with 10 mM ammonium
acetate, pH = 5.5 (A) and ACN (B) as mobile phase from
25% to 60% B in 15 minutes. Combustion data was




To a stirring solution of 3,6-diamino-9-[2-carboxy-4(or
5)-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]phenyl]-4,5-
disulfoxanthylium, inner salt (5 mg, 5.3 × 10-5 mol) in 1
ml dry DMF (stored over molecular sieves) was added via
syringe a 2M solution of 2-[2-(6-chloro-hexyloxy)-
ethoxy]-ethyl-amine (40 µl, 7.95 × 10-5 mol) in CH2Cl2
followed by diisoproplyethylamine (46 µl, 2.6 × 10-4
mol). The reaction mixture was allowed to stir for 12
hours then diluted with 1 ml of water and subjected to
prep HPLC purification. An orange solid was isolated.
Yield: 21 mg, 68%.
λmax: 493 nm; ε: 77,202
HPLC: 10.39 min (63.5%) and 10.70 min (36.5%).
1H NMR (D2O) [5 isomer]: δ = 8.34 (d, 1H, Ar-4), 8.03
(dd, 1H, Ar-6), 7.45 (s, 1H, Ar-7), 7.26 (d, 2H, Ar-1',8'),
6.97 (d, 2H, Ar-2',7',8'), 3.80 (dd, 1H, exchangable, NH),
3.78-3.50 (m, 10H, CH2-O and CH2-NH(CO)), 3.73 (M,
4H, CH-NH+), 3.42 (t, 2H, CH2-Cl), 3.21 (dd, 4H, CH2-
NH+), 1.69-1.24 (m, H8, -CH2-), 1.35 (d, 24H, CH3-CH),
1.35 (t, 6H, CH3-CH2) ppm. [6 isomer]: δ = 8.06 (s, 2H,
Ar-4,7), 7.67 (s, 1H, Ar-5), 7.26 (d, 2H, Ar-1',8'), 6.97 (d,
2H, Ar-2',7',8'), 3.80 (dd, 1H, exchangable, NH), 3.78-
3.50 (m, 10H, CH2-O and CH2-NH(CO)), 3.73 (M, 4H,
CH-NH+), 3.42 (t, 2H, CH2-Cl), 3.21 (dd, 4H, CH2-NH+),
1.69-1.24 (m, H8, -CH2-) ppm, 1.35 (d, 24H, CH3-CH),
1.35 (t, 6H, CH3-CH2) ppm.
MS: m/z Calcd for C31H34ClN3O12S2+: 739.13. Found:
739.30.
EA: Calcd for C47H72ClN5O12S2: C 56.52, H 7.27, N 7.01,
S 6.42, Cl 3.55. Found: C 58.66, H 6.85, N 7.16, S 6.84, Cl
4.62.Page 10 of 14
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hexahydro-1H-thieno [3,4-d]imidazol-4-yl)pentanamido)-3,6,9,12-
tetraoxapentadecan-15-amide
To a stirring solution of biotin-PEO4-propionate succin-
imidyl ester (5 mg, 8.5 × 10-6 mol) in 115 µl dry DMF was
added via syringe a 0.3M solution of 2-[2-(6-chloro-hexy-
loxy)-ethoxy]-ethyl-ammonium chloride (85 µl, 2.55 ×
10-5 mol) in CH2Cl2 followed by one drop of diisoproply-
ethylamine (excess). The reaction mixture was allowed to
stir for 4 hours then diluted to 1 ml of water and subjected
to prep HPLC purification. A white solid was isolated.
Yield: 4.2 mg, 71%.
1H NMR (DMSO-d6) [5 isomer]: δ = 7.88 (t, 1H, exch.,
NH), 7.82 (t, 1H, exch., NH), 6.41 (s, 1H, exch.., biotin-
NH), 6.34 (s, 1H, exch., biotin-NH), 4.30 (m, 1H, CH),
4.12 (M, 1H, CH), 3.62 (t, 2H, CH2-Cl), 3.58 (t, 2H, CH2-
O), 3.50-3.30 (m, 24H, CH2), 3.18 (m, 4H, CH2-N), 3.08
(m, 1H, CH), 2.82 (dd, 1H, CH2), 2.57 (d, 1H, CH2), 2.31
(t, 2H, CH2), 2.06 (t, 2H, CH2), 1.75-1.27 (m, 12H, -CH2-
) ppm.
MS: m/z Calcd for C31H58ClN4O9S+: 697.36 (100%),
698.36 (35.8%), 699.36 (37.3%). Found: 697.64, 699.68.
EA: Calcd for C31H57ClN4O9S: C 53.39, H 8.24, N 8.03, S
4.60, Cl 5.08. Found: C 53.08, H 8.45, N 7.82, S 4.31, Cl
5.03.
TLC (10% MeOH in CH2Cl2, PMA stain): 0.33
Construct design
The HaloTag mammalian expression vector (pHT2,
Promega) contains the open reading frame of the modi-
fied hydrolase gene, which contains a 5' BamHI and 3'
NgoMIV restriction site. The human β1 integrin sequence
was synthesized (Blue Heron) with a signal peptide
(amino acids 1–20), a truncated extracellular domain
(amino acids 190–217, 722–730), a transmembrane
domain (amino acids 731–756), and a truncated cyto-
plasmic domain (amino acids 757–762). The specificity
determining loop was retained in the extracellular
domain [36]. Using the BamHI and NgoMIV sites, Halo-
Tag was cloned downstream of the signal peptide and
upstream of the extracellular domain. The HaloTag pro-
tein was also cloned upstream of three copies of a nuclear
localization sequence (NLS)3 from the simian virus large
T-antigen [23]. The β1Int-HaloTag and HaloTag-(NLS)3
fusion proteins were confirmed by restriction digest anal-
ysis and sequencing. DNA was purified using endofree
maxipreps (Qiagen) for transfection into mammalian cell
lines.
Cell culture and transfection
All procedures were performed at the standard cell grow-
ing conditions of 37°C in an atmosphere of 5% CO2.
HeLa (ATCC #CCL-2), CHO-K1 (ATCC #CCL61),
HEK293 or U2OS (ATCC #HTB-96) cells were maintained
in DMEM, F12 or McCoy 5A media supplemented with
10% fetal bovine serum (Invitrogen, USA) according
ATCC recommendations.
The β1Int-HaloTag fusion protein was transfected into
mammalian cell lines using the cell-specific lipofection
reagents from Mirus, according to manufacturer proto-
cols. Co-transfection experiments using β1Int-HaloTag
and humanized renilla luciferase or monster GFP
(Promega) were done at a 1:1 ratio. Cells stably expressing
β1Int-HaloTag or HaloTag-(NLS)3 were generated using a
3:1 ratio of β1Int-HaloTag or HaloTag-(NLS)3 and pcINeo
(Promega).
Microscopy
Cells were imaged on a confocal microscope FV500
(Olympus, Japan) using a 488 nm Ar/Kr laser line or a
543- or 633-HeNe laser line. Scanning speed and laser
intensity were adjusted to avoid photobleaching of the
fluorophores and damage of the cells. The microscope
was equipped with microenvironmental chamber to
maintain physiological conditions.
Cell labeling
Live cells were labeled for 15 minutes at 37°C with Halo-
Tag® TMR (5 µM), HaloTag® Alexa Fluor® 488 (5 µM), or
HaloTag® PEG-Biotin (10 µM) ligands. Cells were labeled
with individual ligands, or sequentially labeled first with
the HaloTag 488 ligand followed by the HaloTag TMR lig-
and. The cell permeable HaloTag TMR can label the entire
pool of HaloTag protein and the cell impermeable Halo-
Tag 488 ligand can label only surface protein. After labe-
ling, cells were rinsed with fresh media for 15–30
minutes. Cells were then imaged live, or fixed and proc-
essed for immunocytochemistry, or lysed and processed
for SDS-page analysis.
Live cell imaging
To confirm surface expression and functionality of the
HaloTag protein, HEK293 cells stably expressing β1Int-
HaloTag or HaloTag-(NLS)3were labeled with the Halo-
Tag 488 ligand, then rinsed and imaged. To assess spatial
separation of proteins in live cells using the HaloTag tech-
nology, HeLa cells were transiently transfected with the
β1Int-HaloTag protein, and 48 hours later cells were
sequentially labeled with the HaloTag 488 ligand fol-
lowed by the HaloTag TMR ligand. After labeling and rins-
ing, cells were imaged immediately and 12 hours later. To
assess real-time translocation of proteins in live cells using
the HaloTag technology, U2OS cells stably expressing thePage 11 of 14
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HaloTag 488 and TMR ligands, then rinsed, and imaged
immediately followed by every 20 minutes for 17 hours.
Fixed cell imaging
The stability of the covalent bond between the HaloTag
protein and the HaloTag ligands and the resistance of the
fluorescent signal to cell fixatives allows the imaging of
β1Int-HaloTag in fixed cells. HeLa cells were transiently
transfected with the β1Int-HaloTag protein, and 48 hours
later cells were labeled with either the HaloTag 488 or
TMR ligand. For transferrin experiments, cells were simul-
taneously labeled with HaloTag 488 and an Alexa® Fluor
594 transferrin conjugate (Invitrogen, per supplier proto-
col).
Hela cells were fixed with 4% paraformaldehyde for 10
minutes and then rinsed with phosphate buffered saline
(PBS). For Rab4, Rab11 and transferrin studies, cells were
fixed 30 minutes after live cell labeling to allow time for
protein internalization. Cells were blocked in PBS with
5% normal goat serum (Gibco) and 0.1% triton (Sigma),
except for double immunocytochemistry with HaloTag®
and integrin where triton was omitted so cells were non-
permeablized. After block, cells were incubated in the fol-
lowing primary antibodies: HaloTag® (rabbit, 1.5 µg/ml,
Promega), integrin (mouse, 1:100), golgi zone (mouse,
1:20, Chemicon), protein disulfide isomerase (PDI)
(endoplasmic reticulum marker, mouse, 1:350, Abcam),
58 K protein (endoplasmic reticulum intermediate golgi
complex marker, mouse, 1:200, Abcam), rab4 (early
endosome marker, mouse, 1:100, Abcam), rab11 (late
endosome marker, mouse, 1:200, Abcam), and cadherin
(rabbit, 1:600, Abcam). Primary antibodies were removed
and rinsed 3 times with PBS followed by Alexa Fluor®-488
conjugated or Alexa Fluor®-594 conjugated anti-rabbit or
mouse secondary antibodies (goat, 1:1000, Molecular
Probes). Cells were rinsed 3 times with PBS and imaged.
Fluorescence protease protection
To reveal the β1Int-HaloTag protein topology and subcel-
lular localization, we used the HaloTag technology with a
modified fluorescence protease assay – a new technique
that determines the topological distribution of proteins in
living cells by monitoring trypsin-induced destruction of
GFP attached to a protein of interest [24]. To assess pro-
tein topology, HEK293 cells stably expressing the β1Int-
HaloTag protein were sequentially labeled with the Halo-
Tag 488 and TMR ligands. Immediately following labeling
and rinsing, live cells were imaged before trypsin addition
and then imaged at 50 and 450 seconds following 4 mM
trypsin exposure. For additional figure 1, live cells were
imaged 1 hour following labeling and rinsing, thereby
some β1Int-HaloTag that had labeled on the surface with
the HaloTag 488 ligand would internalize before trypsin
addition. To assess subcellular localization, HeLa cells co-
expressing the β1Int-HaloTag protein and GFP (Promega)
were labeled with the HaloTag TMR ligand. Immediately
following labeling and rinsing, live cells were imaged
before digitonin addition and then imaged at 360, 440
and 590 seconds following 80 µM digitonin treatment.
Cell capture
HeLa cells were transiently co-transfected with β1Int-
HaloTag, or HaloTag as a control, and humanized renilla
luciferase. After 48 hours, cells were labeled with the
HaloTag PEG-Biotin ligand, then rinsed, and collected
with 3 mM EDTA. Cells were placed into SA-coated 96
well plates (Pierce) for 30 minutes at 37°C, then wells
were rinsed to remove non-captured cells. Captured cells
were lysed and luciferase activity was measured using the
renilla luciferase assay, per manufacturer protocol
(Promega). Plates were read on a microplate luminometer
(Veritas) and RLU (relative light units) were averaged over
24 wells, with standard error of the mean. To verify spe-
cific capture, SA-coated plates were pre-blocked with the
HaloTag PEG-Biotin ligand (10 µM, for 30 minutes) then
rinsed before cell addition.
For live cell imaging, HEK293 cells stably expressing
β1Int-HaloTag, or wildtype HEK293 as a control, were
labeled with the HaloTag PEG-Biotin ligand, then rinsed,
and collected with 3 mM EDTA. Cells were placed into SA-
coated 96 well plates (Pierce) for 30 minutes at 37°C,
then wells were rinsed to remove non-captured cells. Cap-
tured cells were removed using trypsin-EDTA (Sigma),
replated on glass slides (Nalge Nunc), and labeled after 24
hours with HaloTag TMR ligand and imaged.
Glycosylation and timcourse analysis
To assess the glycosylation and location of separate pro-
tein pools in cells using the HaloTag technology we used
HEK293 cells stably expressing the β1Int-HaloTag pro-
tein. Cells were labeled with the HaloTag 488 ligand
alone, the TMR HaloTag ligand alone, or sequentially.
Cells were then rinsed, collected in 1 × PBS with a protease
inhibitor cocktail (1:100, Sigma), and lysed by fractiona-
tion. After live cell labeling and rinsing, cells were col-
lected either immediately for the glycosylation study or at
times 0–12 hours for the time course study.
Lysate was incubated with either O- or N-glycanase, using
the enzymatic deglycosylation kit, per manufacturer pro-
tocol (Prozyme).
Because the HaloTag ligand is held by a stable covalent
bond, the fluorescently labeled β1Int-HaloTag protein
can be boiled with sample buffer and resolved by SDS-
PAGE without loss of the fluorescence signal. Lysate in
sample buffer (1% SDS, 10% glycerol, and 1.0 mM β-mer-Page 12 of 14
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resolved on SDS-PAGE (4–20% gradient gels, Invitrogen),
with the DyLight fluorescent protein molecular weight
marker (Pierce). Gels were analyzed on a fluorescence
imager Typhoon 9400 (Hitachi, Japan) at an Eex/Eem
appropriate for Alexa Fluor® 488 and TMR.
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Distinguishing cell surface and internalized HaloTag protein. Pre trypsin 
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the red internal protein, and some of the original green surface pool has 
internalized. After trypsin, the external HaloTag 488 ligand is stripped 
over 200 and 400 seconds and the internal HaloTag TMR ligand and 
internalized HaloTag 488 ligand are preserved. Cell images were gener-
ated on an Olympus FV500 confocal microscope in sequential mode using 
appropriate filter sets.




Real-time translocation of proteins using HaloTag Technology. Timelapse 
imaging of live U2OS cells sequentially labeled with HaloTag 488 and 
TMR ligands shows real-time translocation of both protein pools. After 
labeling, time 0 shows spatial separation of the green surface protein 
around the red internal protein. Imaging every 20 minutes over 17 hours 
first shows the green surface pool internalizing and the red internal pool 
trafficking to the surface, then the original green surface pool inside and 
the red pool on the membrane, and finally the red surface pool internaliz-
ing.
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